ProteusDx is a smart capsule endoscopy platform that uses onboard imaging and artificial intelligence (AI) to detect, monitor, and treat gastrointestinal conditions in humans, pets, and horses.
Unlike standard capsule cameras, ProteusDx includes AI-powered image analysis and optional targeted drug delivery (ProteusTx), enabling real-time diagnostics and intervention.
Yes. The base VCE system is FDA-cleared for human use. Additional AI enhancements and therapeutic modules will undergo regulatory submission as part of our phased rollout.
ProteusDx is designed to support diagnosis of GERD, Barrett’s esophagus, ulcers, and other upper GI issues. It will also evolve to support monitoring and therapy delivery.
No. ProteusDx is a swallowable capsule that requires no sedation, scoping, or recovery time-making it suitable for clinics and outpatient settings.
The onboard AI analyzes images in real-time to identify abnormalities like erosions, ulcers, inflammation, and motility issues, with flagged insights sent directly to clinicians.
The capsule is adapted for safe use in dogs, cats, and horses. It can detect gastric ulcers, inflammation, tumors, and other GI issues without requiring anesthesia or invasive scoping.
Yes. The size, coating, and transit properties are tailored for veterinary use, including different versions for large animals like horses and smaller companion pets.
Yes. Through ProteusTx, the capsule can deliver medication directly to inflamed or ulcerated areas, minimizing systemic drug exposure.
The capsule wirelessly transmits data to a receiver or cloud-based portal. Clinicians and veterinarians can access images and AI insights via a secure dashboard.
Most diagnostic scans are completed within a few hours, with analysis and results available the same day.
For chronic conditions, 2–3 uses per year are typical-covering detection, treatment, and follow-up monitoring.
ProteusDx is currently being piloted in veterinary settings and undergoing clinical validation. Human launch is scheduled post-AI clearance and ongoing studies.
Pricing varies by use case and species. A typical range is $1,000–$2,000 per capsule, depending on the functionality (diagnostic vs. therapeutic).
For humans, insurance coverage is anticipated following broader clinical adoption and coding integration. Veterinary applications are primarily cash-pay.